As the demand for app-based services grows, now may be the time to invest in UX research to identify needed improvements and enhancements.
Back to team page
Anke Adenwala
Partner
Anke has spent more than 7 years in the UX field. Much of her recent work has been in the healthcare space, specifically with medical device manufacturers to coordinate and execute human factors research programs. Her experience ranges from exploratory work, through small- and large-scale formative studies, to 510k validation studies, having supported successful submissions and several publications. With a background in social science, Anke enjoys interacting with people to better understand how the devices they interact with impact their lives, and how to optimize these tools to create better experiences. Anke has lived and studied in three countries and speaks German and French. Anke holds an MA in Social Science from the University of Chicago.
Bold facts
Learn more about
Something unique about you summed up in one sentence
Your favorite part of working at Bold Insight
In your spare time (or if you had spare time), you would absolutely do this:
How long have you been in the UX field?
Your favorite city in the world is...and why?
You cannot start the day without doing this:
Your ultimate celebrity dinner party guest list would include:
Long-term personal or professional goal?
- Bold Insight to launch AI research project at the 2024 HFES Health Care Symposium
- Bold Insight to showcase digital IFU design, remote testing, global research expertise at virtual human factors health care conference
- Bold Insight to showcase digital IFU design, global research expertise at human factors health care conference
- When designing an experience, are you really thinking about the customer first?
- Reclassifying diabetes: 3 implications for product design
Read our team’s latest bold insights
Human factors research in the times of COVID
Human factors research in the support of medical and drug delivery device commercialization is essential and we should be planning on a return to in-person research as soon as is possible by applying all available and practical protective measures.
COVID-19: Using human factors and UX to make a positive impact
We have aggregated some considerations for HCPs, healthcare organizations, and others involved in the medical space.
Is FMEA inadequate for human factors analyses?
A “traditional” risk assessment does not meet the needs of FDA-required human factors analyses.